4D Molecular Therapeutics

4D Molecular Therapeutics is one of the...

• Russell 3000.

4D Molecular Therapeutics is a company listed under the stock ticker FDMT (US).

View the org chart displaying its 26 main executives

Most searched biographies at 4D Molecular Therapeutics

• David Kirn, Chief Executive Officer and Director
• Susannah Gray, Director
• Jacob Chacko, Board Member

Popular executive movements at 4D Molecular Therapeutics

• Noriyuki Kasahara, who was Director, is promoted to Chief Scientific Officer  (posted on January 5 2024).
• August Moretti, Chief Financial Officer, has left the company  (posted on September 13 2023).
• Uneek Mehra has joined the company as Chief Financial and Business Officer  (posted on September 13 2023).

Create your alert
to follow the executive moves at 4D Molecular Therapeutics.

4D Molecular Therapeutics has 2,281 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
• Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
• Histogen has filed for bankruptcy protection  (posted on April 19 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by 4D Molecular Therapeutics

• Press Releases - 4D Molecular Therapeutics
• Press Releases - 4D Molecular Therapeutics

Social media about 4D Molecular Therapeutics

• 4D Molecular Therapeutics on Wikipedia, Google News & Yahoo Finance
• 4D Molecular Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including David Kirn

Call 4D Molecular Therapeutics at +1 51...

View the org chart

Register to receive your alert

Report an error